Walgreens Boots Alliance Inc
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy… Read more
Walgreens Boots Alliance Inc (WBA) - Net Assets
Latest net assets as of May 2025: $7.32 Billion USD
Based on the latest financial reports, Walgreens Boots Alliance Inc (WBA) has net assets worth $7.32 Billion USD as of May 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($69.41 Billion) and total liabilities ($62.09 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $7.32 Billion |
| % of Total Assets | 10.55% |
| Annual Growth Rate | 8.64% |
| 5-Year Change | -42.37% |
| 10-Year Change | -61.09% |
| Growth Volatility | 15.86 |
Walgreens Boots Alliance Inc - Net Assets Trend (1985–2024)
This chart illustrates how Walgreens Boots Alliance Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Walgreens Boots Alliance Inc (1985–2024)
The table below shows the annual net assets of Walgreens Boots Alliance Inc from 1985 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-08-31 | $12.18 Billion | -57.25% |
| 2023-08-31 | $28.49 Billion | -6.31% |
| 2022-08-31 | $30.41 Billion | +27.65% |
| 2021-08-31 | $23.82 Billion | +12.71% |
| 2020-08-31 | $21.14 Billion | -14.75% |
| 2019-08-31 | $24.79 Billion | -7.10% |
| 2018-08-31 | $26.69 Billion | -5.61% |
| 2017-08-31 | $28.27 Billion | -6.63% |
| 2016-08-31 | $30.28 Billion | -3.26% |
| 2015-08-31 | $31.30 Billion | +52.23% |
| 2014-08-31 | $20.56 Billion | +5.69% |
| 2013-08-31 | $19.45 Billion | +6.68% |
| 2012-08-31 | $18.24 Billion | +22.83% |
| 2011-08-31 | $14.85 Billion | +3.10% |
| 2010-08-31 | $14.40 Billion | +0.17% |
| 2009-08-31 | $14.38 Billion | +11.71% |
| 2008-08-31 | $12.87 Billion | +15.90% |
| 2007-08-31 | $11.10 Billion | +9.77% |
| 2006-08-31 | $10.12 Billion | +13.79% |
| 2005-08-31 | $8.89 Billion | +8.04% |
| 2004-08-31 | $8.23 Billion | +14.35% |
| 2003-08-31 | $7.20 Billion | +15.50% |
| 2002-08-31 | $6.23 Billion | +19.65% |
| 2001-08-31 | $5.21 Billion | +22.99% |
| 2000-08-31 | $4.23 Billion | +21.52% |
| 1999-08-31 | $3.48 Billion | +22.30% |
| 1998-08-31 | $2.85 Billion | +20.06% |
| 1997-08-31 | $2.37 Billion | +16.15% |
| 1996-08-31 | $2.04 Billion | +13.97% |
| 1995-08-31 | $1.79 Billion | +13.92% |
| 1994-08-31 | $1.57 Billion | +14.13% |
| 1993-08-31 | $1.38 Billion | +11.80% |
| 1992-08-31 | $1.23 Billion | +14.07% |
| 1991-08-31 | $1.08 Billion | +14.13% |
| 1990-08-31 | $947.30 Million | +15.05% |
| 1989-08-31 | $823.40 Million | +15.55% |
| 1988-08-31 | $712.60 Million | +14.51% |
| 1987-08-31 | $622.30 Million | +12.41% |
| 1986-08-31 | $553.60 Million | +15.09% |
| 1985-08-31 | $481.00 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Walgreens Boots Alliance Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 5693.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (August 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $23.35 Billion | 223.53% |
| Common Stock | $12.00 Million | 0.11% |
| Other Comprehensive Income | $-2.90 Billion | -27.75% |
| Total Equity | $10.45 Billion | 100.00% |
Walgreens Boots Alliance Inc Competitors by Market Cap
The table below lists competitors of Walgreens Boots Alliance Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Owens Corning Inc
NYSE:OC
|
$8.58 Billion |
|
JCET Group Co Ltd
SHG:600584
|
$8.59 Billion |
|
Akbank Turk Anonim Sirketi
OTCQX:AKBTY
|
$8.60 Billion |
|
New Oriental Education & Technology Group Inc
MX:EDUN
|
$8.60 Billion |
|
Crane Company
NYSE:CR
|
$8.56 Billion |
|
Galp Energia Nom
IL:0B67
|
$8.55 Billion |
|
Cipla Limited
NSE:CIPLA
|
$8.55 Billion |
|
Shennan Circuits Co Ltd Class A
SHE:002916
|
$8.55 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Walgreens Boots Alliance Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 20,021,000,000 to 10,445,000,000, a change of -9,576,000,000 (-47.8%).
- Net loss of 8,636,000,000 reduced equity.
- Dividend payments of 1,260,000,000 reduced retained earnings.
- Share repurchases of 69,000,000 reduced equity.
- Other comprehensive income increased equity by 95,000,000.
- Other factors increased equity by 294,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-8.64 Billion | -82.68% |
| Dividends Paid | $1.26 Billion | -12.06% |
| Share Repurchases | $69.00 Million | -0.66% |
| Other Comprehensive Income | $95.00 Million | +0.91% |
| Other Changes | $294.00 Million | +2.81% |
| Total Change | $- | -47.83% |
Book Value vs Market Value Analysis
This analysis compares Walgreens Boots Alliance Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.99x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 24.47x to 0.99x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1985-08-31 | $0.49 | $11.98 | x |
| 1986-08-31 | $0.56 | $11.98 | x |
| 1987-08-31 | $0.63 | $11.98 | x |
| 1988-08-31 | $0.72 | $11.98 | x |
| 1989-08-31 | $0.84 | $11.98 | x |
| 1990-08-31 | $0.96 | $11.98 | x |
| 1991-08-31 | $1.10 | $11.98 | x |
| 1992-08-31 | $1.25 | $11.98 | x |
| 1993-08-31 | $1.40 | $11.98 | x |
| 1994-08-31 | $1.59 | $11.98 | x |
| 1995-08-31 | $1.82 | $11.98 | x |
| 1996-08-31 | $2.06 | $11.98 | x |
| 1997-08-31 | $2.40 | $11.98 | x |
| 1998-08-31 | $2.85 | $11.98 | x |
| 1999-08-31 | $3.44 | $11.98 | x |
| 2000-08-31 | $4.15 | $11.98 | x |
| 2001-08-31 | $5.06 | $11.98 | x |
| 2002-08-31 | $6.04 | $11.98 | x |
| 2003-08-31 | $6.98 | $11.98 | x |
| 2004-08-31 | $7.97 | $11.98 | x |
| 2005-08-31 | $8.64 | $11.98 | x |
| 2006-08-31 | $9.92 | $11.98 | x |
| 2007-08-31 | $11.03 | $11.98 | x |
| 2008-08-31 | $12.93 | $11.98 | x |
| 2009-08-31 | $14.50 | $11.98 | x |
| 2010-08-31 | $14.58 | $11.98 | x |
| 2011-08-31 | $16.06 | $11.98 | x |
| 2012-08-31 | $20.72 | $11.98 | x |
| 2013-08-31 | $20.37 | $11.98 | x |
| 2014-08-31 | $21.30 | $11.98 | x |
| 2015-08-31 | $29.70 | $11.98 | x |
| 2016-08-31 | $27.75 | $11.98 | x |
| 2017-08-31 | $26.22 | $11.98 | x |
| 2018-08-31 | $26.82 | $11.98 | x |
| 2019-08-31 | $26.15 | $11.98 | x |
| 2020-08-31 | $24.01 | $11.98 | x |
| 2021-08-31 | $27.50 | $11.98 | x |
| 2022-08-31 | $33.91 | $11.98 | x |
| 2023-08-31 | $23.19 | $11.98 | x |
| 2024-08-31 | $12.10 | $11.98 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Walgreens Boots Alliance Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -82.68%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -5.85%
- • Asset Turnover: 1.82x
- • Equity Multiplier: 7.76x
- Recent ROE (-82.68%) is below the historical average (12.81%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1985 | 19.58% | 2.98% | 3.29x | 2.00x | $46.10 Million |
| 1986 | 18.62% | 2.82% | 3.06x | 2.16x | $47.74 Million |
| 1987 | 16.63% | 2.42% | 3.14x | 2.19x | $41.27 Million |
| 1988 | 18.12% | 2.64% | 3.23x | 2.12x | $57.84 Million |
| 1989 | 18.73% | 2.87% | 3.20x | 2.04x | $71.86 Million |
| 1990 | 18.43% | 2.89% | 3.16x | 2.02x | $79.87 Million |
| 1991 | 18.04% | 2.90% | 3.21x | 1.94x | $86.88 Million |
| 1992 | 17.89% | 2.95% | 3.15x | 1.92x | $97.27 Million |
| 1993 | 16.08% | 2.67% | 3.27x | 1.84x | $83.82 Million |
| 1994 | 17.91% | 3.05% | 3.17x | 1.85x | $124.54 Million |
| 1995 | 17.90% | 3.09% | 3.20x | 1.81x | $141.54 Million |
| 1996 | 18.19% | 3.16% | 3.24x | 1.78x | $167.39 Million |
| 1997 | 18.37% | 3.26% | 3.18x | 1.77x | $198.70 Million |
| 1998 | 17.94% | 3.34% | 3.12x | 1.72x | $226.10 Million |
| 1999 | 17.91% | 3.50% | 3.02x | 1.70x | $275.67 Million |
| 2000 | 18.35% | 3.66% | 2.99x | 1.68x | $353.50 Million |
| 2001 | 17.01% | 3.60% | 2.79x | 1.70x | $364.88 Million |
| 2002 | 16.36% | 3.55% | 2.90x | 1.59x | $396.18 Million |
| 2003 | 16.34% | 3.62% | 2.85x | 1.59x | $456.13 Million |
| 2004 | 16.53% | 3.63% | 2.81x | 1.62x | $537.40 Million |
| 2005 | 17.54% | 3.70% | 2.89x | 1.64x | $670.53 Million |
| 2006 | 17.31% | 3.69% | 2.77x | 1.69x | $739.02 Million |
| 2007 | 18.38% | 3.80% | 2.78x | 1.74x | $930.87 Million |
| 2008 | 16.76% | 3.65% | 2.63x | 1.74x | $869.76 Million |
| 2009 | 13.95% | 3.17% | 2.52x | 1.75x | $568.40 Million |
| 2010 | 14.52% | 3.10% | 2.57x | 1.82x | $651.00 Million |
| 2011 | 18.28% | 3.76% | 2.63x | 1.85x | $1.23 Billion |
| 2012 | 11.66% | 2.97% | 2.14x | 1.83x | $303.40 Million |
| 2013 | 13.10% | 3.53% | 2.04x | 1.82x | $602.60 Million |
| 2014 | 9.40% | 2.53% | 2.05x | 1.81x | $-124.10 Million |
| 2015 | 13.48% | 4.08% | 1.50x | 2.20x | $1.09 Billion |
| 2016 | 13.78% | 3.56% | 1.61x | 2.40x | $1.14 Billion |
| 2017 | 14.42% | 3.45% | 1.79x | 2.33x | $1.25 Billion |
| 2018 | 18.82% | 3.82% | 1.93x | 2.55x | $2.36 Billion |
| 2019 | 16.49% | 3.32% | 1.76x | 2.83x | $1.57 Billion |
| 2020 | 2.16% | 0.37% | 1.40x | 4.12x | $-1.66 Billion |
| 2021 | 10.67% | 1.92% | 1.63x | 3.41x | $159.80 Million |
| 2022 | 14.77% | 3.27% | 1.47x | 3.07x | $1.40 Billion |
| 2023 | -15.38% | -2.21% | 1.44x | 4.83x | $-5.08 Billion |
| 2024 | -82.68% | -5.85% | 1.82x | 7.76x | $-9.68 Billion |
Industry Comparison
This section compares Walgreens Boots Alliance Inc's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $239,198,060
- Average return on equity (ROE) among peers: -6.39%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Walgreens Boots Alliance Inc (WBA) | $7.32 Billion | 19.58% | 8.48x | $8.58 Billion |
| Alibaba Health Information Technology Limited (ALBBY) | $1.12 Billion | -18.54% | 0.50x | $12.50 Billion |
| Allstar Health Brands Inc (ALST) | $-9.92 Million | 0.00% | 0.00x | $3.80 |
| Bimi International Medical Inc (BIMI) | $-409.66K | 0.00% | 0.00x | $296.83 |
| Blum Holdings Inc (BLMH) | $-4.74 Million | 0.00% | 0.00x | $8.97 Million |
| China Jo-Jo Drugstores Inc (CJJD) | $26.66 Million | -21.17% | 1.52x | $5.94 Million |
| Clicks Group Ltd (CLCGY) | $1.13 Billion | 41.98% | 2.72x | $4.80 Billion |
| China BCT Pharmacy Group Inc (CNBI) | $134.27 Million | 15.68% | 0.82x | $0.93 |
| Dalrada Financial Corp (DFCO) | $4.40 Million | -81.82% | 0.55x | $1.57 Million |
| Health Advance Inc (HADV) | $-105.34K | 0.00% | 0.00x | $25.40K |
| Healthwarehouse.Com (HEWA) | $-3.10 Million | 0.00% | 0.00x | $741.12 |